Spironolactone Tablets 25mg (Aldactone-A® / アルダクトンA錠25mg)

JPY ¥1,700

Japanese anti-aldosterone diuretic and antihypertensive agent (Spironolactone 25mg). Oral tablet for hypertension, edema, and primary aldosteronism. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Pfizer Japan Inc., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,564
10 - 19 12% JPY ¥1,496
20 + 18% JPY ¥1,394
SKU: ALD-25-TAB Category:

Description

Product Overview / 商品概要

Aldactone-A Tablets 25mg (アルダクトンA錠25mg)
Generic: Spironolactone / スピロノラクトン
Therapeutic Category: Anti-aldosterone diuretic and antihypertensive agent / 抗アルドステロン性利尿・降圧剤
Manufactured by: Pfizer Japan Inc. / ファイザー株式会社

Composition & Specification / 組成・規格

Active Ingredient: Spironolactone (JP) 25mg per tablet / 1錠中 日局 スピロノラクトン(25mg)
Additives: Light anhydrous silicic acid, Magnesium stearate, Lactose hydrate, Hydroxypropylcellulose, Flavoring / 軽質無水ケイ酸、ステアリン酸マグネシウム、乳糖水和物、ヒドロキシプロピルセルロース、香料
Appearance: White uncoated tablet, identification code: SEARLE 101, diameter 7.0mm, thickness 3.0mm, weight 100mg
外観: 白色素錠、識別コード: SEARLE 101、直径7.0mm、厚さ3.0mm、重量100mg

Indications / 効能効果

EN: Hypertension (essential, renal, etc.); cardiac edema (congestive heart failure), renal edema, hepatic edema, idiopathic edema, edema and ascites associated with malignant tumors, nutritional edema; diagnosis and symptomatic improvement of primary aldosteronism
JA: 高血圧症(本態性、腎性等)、心性浮腫(うっ血性心不全)、腎性浮腫、肝性浮腫、特発性浮腫、悪性腫瘍に伴う浮腫および腹水、栄養失調性浮腫、原発性アルドステロン症の診断および症状の改善

Dosage and Administration / 用法用量

EN: The usual adult dose is 50–100 mg of spironolactone per day, administered orally in divided doses. Adjust as appropriate based on age and clinical condition. Combination with other agents is common for indications other than diagnosis and symptomatic improvement of primary aldosteronism.
JA: スピロノラクトンとして、通常成人1日50~100mgを分割経口投与する。なお、年齢、症状により適宜増減する。ただし、「原発性アルドステロン症の診断および症状の改善」のほかは他剤と併用することが多い。

Contraindications / 禁忌

EN: Patients with anuria or acute renal failure; patients with hyperkalemia; patients with Addison’s disease; patients receiving tacrolimus, eplerenone, esaxerenone, or mitotane; patients with a history of hypersensitivity to this product
JA: 無尿又は急性腎不全の患者、高カリウム血症の患者、アジソン病の患者、タクロリムス・エプレレノン・エサキセレノン又はミトタンを投与中の患者、本剤に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 21900AMX00700
Sales Started: November 1963 / 1963年11月
Classification Code: 872133
Storage: Store at room temperature / 室温保存
Shelf Life: 5 years / 5年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10], 300 tablets [10 tablets (PTP) x 30], 100 tablets (bottle)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Spironolactone Tablets 25mg (Aldactone-A® / アルダクトンA錠25mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Spironolactone Tablets 25mg (Aldactone-A®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.